Rescinnamine

Rescinnamine
Clinical data
Routes of; administration	oral
ATC code	C02AA01 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
CAS Number	24815-24-5;
PubChem CID	32681;
DrugBank	APRD00112;
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C35H42N2O9
Molar mass	634.716 g/mol

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Rescinnamine is an angiotensin-converting enzyme inhibitor used as an antihypertensive drug. It is an alkaloid obtained from Rauwolfia serpentina and other species of Rauwolfia.

Moderil®, Cinnasil®, Anaprel®

v t e Antihypertensives (C02) and diuretics (C03)
Sympatholytic agents	Template:Navbox subgroup
Vasodilators	Diazoxide • hydrazinophthalazine (Hydralazine, Dihydralazine, Endralazine, Cadralazine) • Minoxidil • Nitroprusside • Phentolamine
Other antihypertensives	serotonin antagonist (Ketanserin) • endothelin receptor antagonist (Bosentan, Ambrisentan, Sitaxsentan) • MAOI (Pargyline) • THI (Metirosine)
Diuretics	Template:Navbox subgroup

Clinical data

Routes of administration	oral
ATC code	C02AA01 (WHO)
Legal status
Legal status	In general: ℞ (Prescription only)
Identifiers
CAS Number	24815-24-5
PubChem CID	32681
DrugBank	APRD00112
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
Formula	C₃₅H₄₂N₂O₉
Molar mass	634.716 g/mol